Teriflunomide added to interferon-β in relapsing multiple sclerosis
M. S. Freedman(National Multiple Sclerosis Society), K. Ton(The University of Texas Health Science Center at Houston), Klaus Tiel‐Wilck, Catherine Simonson(Université Claude Bernard Lyon 1), Tomas Olsson(Karolinska University Hospital), Michael Stein(Neurological Research Institute), Javier Olascoaga(School of the Art Institute of Chicago), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), Flavia Nelson(Cleveland Clinic), Óscar Fernández(Universidad de Málaga), Renjie He(The University of Texas Health Science Center at Houston), Cynthia Huffman(Meridien Research), Ruggero Capra(Presidio Ospedaliero), Ponnada A. Narayana(Vignan's Foundation for Science, Technology & Research), Eckart Lensch(Deutsche Klinik für Diagnostik), Antonio García Merino(Hospital Universitario Puerta de Hierro Majadahonda), Hadj Benzerdjeb(Université Claude Bernard Lyon 1), Daniel Kantor(University of Florida), Ludwig Kappos(Novartis (Switzerland)), Irina Vainrub(The University of Texas Health Science Center at Houston), François Grand’Maison, François Jacques, Txomin Arbizu(Bellvitge University Hospital), Jerry S. Wolinsky(The University of Texas Health Science Center at Houston), Carlo Pozzilli(Ophthalmology Clinic), Barbara D. Wamil(Université Claude Bernard Lyon 1), M. Kremenchutzky, Ruth Ann Marrie(Manitoba Health), Cristoforo Comi(Vita-Salute San Raffaele University), Barry Hendin, Paul O’Connor, Aaron Miller(Icahn School of Medicine at Mount Sinai), Mathias Mäurer, Albert Saiz(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Rafael Arroyo, Tjalf Ziemssen(University Hospital Carl Gustav Carus), Wolfgang-Gerhard Elias, Christian Confavreux(Hôpital Pierre Wertheimer), Karl Otta Sigel(Praxis), Sushmita Datta(The University of Texas Health Science Center at Houston), Brandi Gates(The University of Texas Health Science Center at Houston), J. Meca(Hospital Universitario Virgen de la Arrixaca), H. Li(Université Claude Bernard Lyon 1), Suzanne Gazda(Integra (United States)), Alfredo Rodríguez Antigüedad(School of the Art Institute of Chicago)
Cited by 78
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k